Story
US Senators Question Health Secretary Kennedy Over Conflicting Gardasil Settlement Disclosures

A group of Democratic U.S. senators is questioning Health Secretary Robert F. Kennedy Jr. over conflicting statements regarding his financial stake in litigation involving Merck's Gardasil vaccine. In a letter sent Monday, the lawmakers highlight an apparent contradiction between Kennedy's previous testimony and federal ethics filings and his more recent public comments.
Discrepancy Over Divestment
The issue centers on a $50 million settlement Merck agreed to pay earlier this year to resolve lawsuits over its Gardasil HPV vaccine. Before his appointment, Kennedy was an attorney of record for some plaintiffs and was entitled to a potential fee.
During his confirmation process, Kennedy addressed concerns about this conflict of interest by stating in written testimony and ethics filings that he would transfer his financial interest in the vaccine litigation to his son. However, in a social media post this month, Kennedy said that neither he nor his family had "received a penny" from the settlement and that he had "relinquished any interest" back to the Wisner Baum law firm before taking office.
Lawmakers Demand Clarification
The letter, authored by Senator Elizabeth Warren and three colleagues, states that Kennedy's recent claim appears to indicate the information he previously provided to Congress "is no longer accurate." The senators wrote that this suggests he has "either modified your ethics agreement or strayed from it altogether," according to the letter reviewed by Reuters.
AdThe senators' staff found no subsequent ethics filings that would reflect a change in the divestment plan. The lawmakers have asked Kennedy to explain the discrepancy and clarify why he certified on an ethics form that he would transfer the stake to a family member if that did not occur.
Context and Conflict of Interest
As Secretary of Health and Human Services (HHS), Kennedy oversees agencies, including the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), that regulate, study, and make recommendations about vaccines. This role creates a potential conflict of interest given his past involvement in vaccine-related litigation.
An HHS spokesperson did not immediately respond to a request for comment on the new letter, Reuters reported. When previously asked about the matter last month, a spokesperson pointed to Kennedy's social media posting.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.